Lixte Stock Buy Hold or Sell Recommendation

LIXT -  USA Stock  

USD 2.76  0.03  1.08%

Given the investment horizon of 90 days and your way above-average risk tolerance, our recommendation regarding Lixte Biotech Hlds is 'Strong Sell'. Macroaxis provides Lixte Biotech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LIXT positions. The advice algorithm takes into account all of Lixte Biotech's available fundamental, technical, and predictive indicators you will find on this site.

Search Advice 

 
Refresh
The advice is provided from Lixte Biotech's buy-and-hold perspective. Additionally, see Lixte Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Lixte and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Lixte Biotech Hlds.

Execute Lixte Biotech Buy or Sell Advice

The Lixte recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Lixte Biotech Hlds. Macroaxis does not own or have any residual interests in Lixte Biotech Hlds or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Lixte Biotech's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Lixte BiotechBuy Lixte Biotech
Strong Sell

Volatility

Very riskyDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds of Distress

Significantly HighDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Lixte Biotech Hlds has a Mean Deviation of 3.54, Semi Deviation of 4.18, Standard Deviation of 4.72, Variance of 22.26, Downside Variance of 19.35 and Semi Variance of 17.5
We provide investment recommendation to complement the last-minute expert consensus on Lixte Biotech Hlds. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Lixte Biotech Hlds is not overpriced, please verify all Lixte Biotech Hlds fundamentals, including its book value per share, as well as the relationship between the market capitalization and z score . Please also check out Lixte Biotech price to earning to check your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Lixte Biotech Trading Alerts and Improvement Suggestions

Lixte Biotech Hlds has very high historical volatility over the last 90 days
Lixte Biotech Hlds has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 200 K. Net Loss for the year was (4.61 M) with profit before overhead, payroll, taxes, and interest of 0.
Lixte Biotech Hlds currently holds about 7.74 M in cash with (2.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.57.
Roughly 68.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Lixte Biotech exotic insider transaction detected

Lixte Biotech Returns Distribution Density

The distribution of Lixte Biotech's historical returns is an attempt to chart the future uncertainty of Lixte Biotech's future price movements. The chart of the probability distribution of Lixte Biotech stock daily returns describes the distribution of returns around its average expected value. We use Lixte Biotech Hlds price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Lixte Biotech returns is essential to provide solid investment advice for Lixte Biotech stock.
Mean Return0.23Value At Risk-7.27
Potential Upside6.19Standard Deviation4.72
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Lixte Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Lixte Biotech Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Lixte Biotech or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Lixte Biotech stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Lixte stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
0.21
β
Beta against DOW0.34
σ
Overall volatility
4.51
Ir
Information ratio 0.0388

Lixte Biotech Volatility Alert

Lixte Biotech Hlds exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Lixte Biotech Hlds individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Lixte Biotech future systematic risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Lixte Biotech's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Lixte Biotech's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Lixte Biotech Fundamentals Vs Peers

Comparing Lixte Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Lixte Biotech's direct or indirect competition across all of the common fundamentals between Lixte Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Lixte Biotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Lixte Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Lixte Biotech by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Lixte Biotech to competition
FundamentalsLixte BiotechPeer Average
Return On Equity(95.04) %(0.31) %
Return On Asset(56.61) %(0.14) %
Current Valuation35.93 M16.62 B
Shares Outstanding13.54 M571.82 M
Shares Owned by Insiders67.85 %10.09 %
Shares Owned by Institutions9.80 %39.21 %
Number of Shares Shorted29.88 K4.71 M
Price to Earning(2.96) X28.72 X
Price to Book22.95 X9.51 X
Price to Sales28.72 X11.42 X
Revenue200 K9.43 B
Net Income(4.61 M)570.98 M
Cash and Equivalents7.74 M2.7 B
Cash per Share0.57 X5.01 X
Debt to Equity0.16 %48.70 %
Current Ratio32.55 X2.16 X
Book Value Per Share0.12 X1.93 K
Cash Flow from Operations(2.74 M)971.22 M
Short Ratio0.06 X4.00 X
Earnings Per Share(0.29) X3.12 X
Number of Employees318.84 K
Beta-1.08-0.15
Market Capitalization37.91 M19.03 B
Total Asset1.38 M29.47 B
Retained Earnings(19.54 M)9.33 B
Working Capital1.24 M1.48 B
Current Asset1.38 M9.34 B
Current Liabilities140 K7.9 B
Z Score-19.68.72
   Lixte Biotech exotic insider transaction detected [view details]

About Lixte Biotech Buy or Sell Advice

When is the right time to buy or sell Lixte Biotech Hlds? Buying financial instruments such as Lixte Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Lixte Biotech investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Lixte Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Blend Thematic Idea Now

Small Blend
Small Blend Theme
Fund or Etfs that invest in stocks of small to mid-sized entities that have characteristics of both growth and value companies. Small Blend theme has 40 constituents.
View All  Next Launch Small Blend
Additionally, see Lixte Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Lixte Biotech Hlds information on this page should be used as a complementary analysis to other Lixte Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Lixte Stock analysis

When running Lixte Biotech Hlds price analysis, check to measure Lixte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotech is operating at the current time. Most of Lixte Biotech's value examination focuses on studying past and present price action to predict the probability of Lixte Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lixte Biotech's price. Additionally, you may evaluate how the addition of Lixte Biotech to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
The market value of Lixte Biotech Hlds is measured differently than its book value, which is the value of Lixte that is recorded on the company's balance sheet. Investors also form their own opinion of Lixte Biotech's value that differs from its market value or its book value, called intrinsic value, which is Lixte Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lixte Biotech's market value can be influenced by many factors that don't directly affect Lixte Biotech Hlds underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lixte Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Lixte Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lixte Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.